Progressive Supranuclear Palsy Clinical Trials

Find Progressive Supranuclear Palsy Clinical Trials Near You

Transcranial Direct Current Stimulation as a Treatment for Motor Function in Participants Living With Progressive Supranuclear Palsy, Corticalbasal Syndrome Degeneration, or Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Previous preliminary results are sufficiently impressive to suggest that tDCS stimulation does have the potential to improve motor function when that ability is trained during stimulation. In the proposed study, the investigation will assess whether walking sessions combined with tDCS lead to improvements in motor function: gait, articulation, eye gaze, and motor dexterity. In addition, the investigators wish to examine if such results can be replicated in people with other conditions, such as cortical basal syndrome, and Parkinson's disease.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• \- 1. Participants must be able to walk unassisted, or with the assistance of a walker or cane, and be individuals who walk daily.

• 2\. Participants should have a sufficient level of English to be able to express themselves verbally, be able to read and follow instructions.

Locations
Other Locations
Canada
Baycrest Academy of Health Sciences and Geriatric Research
RECRUITING
Toronto
Contact Information
Primary
Alice Zhang, B.Sc
azhang4@research.baycrest.org
(416) 785-2500
Backup
Tyler Roncero, Ph.D
croncero@research.baycrest.org
T (416) 785-2500
Time Frame
Start Date: 2025-10-30
Estimated Completion Date: 2030-12
Participants
Target number of participants: 20
Treatments
Experimental: Real tDCS Stimulation:
Participants will be exposed to 20 min of tDCS brain stimulation while undergoing training on cognitive tasks.
Placebo_comparator: Sham Arm
Participants will be exposed to 20 min of tDCS sham/placebo stimulation while undergoing training on cognitive tasks. Participants will have the exact same apparatus used but with no stimulation.
Sponsors
Leads: Baycrest

This content was sourced from clinicaltrials.gov